Skip to main content

Tracking malaria health disbursements by source in Zambia, 2009–2018: an economic modelling study



Zambia has made profound strides in reducing both the incidence and prevalence of malaria followed by reducing malaria related deaths between 2009 and 2018. The number of partners providing malaria funding has significantly increased in the same period. The increasing number of partners and the subsequent reduction of the number of reported malaria cases in the Ministry of Health main data repository Health Management Information System (HMIS) stimulated this research. The study aimed at (1) identifying major sources of malaria funding in Zambia; (2) describe malaria funding per targeted interventions and (3) relating malaria funding with malaria disease burden.


Data was collected using extensive literature review of institutional strategic document between the year 2009 to 2018, assuming one-year time lag between investment and the health outcome across all interventions. The National’s Health Management Information System (HMIS) provided information on annual malaria admission cases and outpatient clinic record. The statistical package for social sciences (SPSS) alongside Microsoft excel was used to analyze data in the year 2019.


The investigation observed that about 30% of the funding came from PMI/USAID, 26% from the global funds, the government of Zambia contributed 17% and other partners sharing the remaining 27%. Multivariate regression analysis suggests a positive correlation between reducing reported malaria disease burden in HMIS 2009–2018 and concurrent increasing program/intervention funding towards ITNs, IRS, MDA, and Case Management with r2 = 77% (r2 > 0.77; 95% CI: 0.72–0.81). Furthermore, IRS showed a p-value 0.018 while ITNs, Case Management and MDA having 0.029, 0.030 and 0.040 respectively.


Our findings highlight annual funding towards specific malaria intervention reduced the number of malaria admission cases.


Malaria infections are caused by a plasmodium parasite which spreads to people through the bites of infected female Anopheles mosquitoes. In 2017, an estimated 229 million cases of malaria were recorded worldwide and 409,000 people died, mostly children in the African region [1]. Malaria occurs in more than 100 countries and territories. About half of the world's population is at risk. Large areas of Africa and South Asia and parts of Central and South America, the Caribbean, Southeast Asia, the Middle East, and Oceania are considered areas where malaria transmission occurs. In the global community, about 111 countries globally have eliminated malaria and another 35 countries, are making progress toward elimination of the disease [2]. The African region accounts for most global cases of malaria (88%), followed by the Southeast Asia region (10%) and the Eastern Mediterranean region (2%).

In Zambia plasmodium falciparum malaria is endemic throughout the country, with the main transmission season being between November and March every-year. The Malaria Indicator Survey (2008) indicates that the country’s average parasite rate was found to be 10%, with some parts of the country reporting less than 1%, while others still have high parasite prevalence rates of up to 20%-30% [3, 4].

Malaria has for a long time remained the leading cause of morbidity and mortality in Zambia with recent statistics suggesting malaria still being the leading cause of morbidity and the second leading cause of mortality, surpassed only by HIV and AIDS. Also, malaria accounts for up to 40% of all infant mortality and 20% of all maternal mortality in Zambia, and represents a major socio-economic burden on the country, particularly on the communities living in malaria endemic areas [5, 6].

Zambia has shown strong growth in the last decade, reaching lower-middle-income status. Nevertheless, the health sector continues to be dependent on external resources, which has accounted for over 60% percent of health expenditure in recent years. Out-of-pocket health expenditure contributes 12.8% to total health expenditure. Private medical schemes and insurance account for about 5% [7].

Malaria remains a major public health problem in Zambia, despite significant progress made in fighting the disease in the last decade. Malaria prevalence varies across all provinces and districts with 18 million people at risk, including the most vulnerable groups, such as pregnant women and children. The country’s last two iterations of the National Malaria Strategic Plan aimed to reduce transmission and in the current NMSP (2017–2021) the government of Zambia through the ministry of health and the national malaria elimination program (NMEP) adopted an ambitious agenda to eliminate malaria by use of scientific proven interventions for prevention, control, curative, and inclusion of new tools of innovations in strengthening of routine surveillance at all levels. The efforts towards nationwide malaria elimination with regard to malaria case management, emphasizes the need to have diagnostic and curative services as close to home as possible, utilizing community health workers as extensions for the health facility within the community [8, 9, 10]. Despite a better understanding of pathophysiology and management of malaria, childhood mortality remains unacceptably high [11].

Over the past 10 years, Zambia has significantly intensified efforts against malaria by initiating and scaling up the implementation of internationally accepted strategies and best practices for prevention, treatment, and care for malaria [12, 13]. These include: vector control, through indoor residual spraying (IRS) and the promotion of ownership and correct use of insecticide-treated bed nets (ITNs); intermittent preventive treatment in pregnancy (IPTp); prompt and effective malaria case management; Coartem (artemether/lumefantriine) use; and the introduction and scaling up of Rapid Diagnostic Tests (RDTs) in health facilities that do not have microscopy services [14]. On the other hand, if no new control measures are developed, the malaria death toll is expected to raise as actual figures could be potentially higher as a result of under-reporting and challenges in diagnosis [15].

It was observed that the increasing malaria disease burden can only be contained through harnessing, harmonization and coordination of all the available resources, to maximize the benefits from synergies. In this respect, the national malaria control program (NMCP) has successfully established strong partnerships with the communities, other government line ministries and departments, the faith-based health sector under the coordination of the private sector, civil society, and the global community. Strong, effective, and coordinated partnerships have been established with the global community, through the RBM Partnerships, leading to significant technical, financial, and logistical support. Also, reference documents such as the world malaria report present a scope on source of funding partners and reflects their mandate and area of support. However, provided funding is sustained there is need to harness the fragmented information into one document thereby providing an opportunity to gauge and categories related interventions. In addition, the main data repository for ministry of health (DHIS) only present data in its raw form without linking the disease burden to available funds and interventions. The researcher believes that malaria disease burden, (trends and prevalence) cannot be understood fully unless there is an attempt to discuss the disease burden in light of the country’s funding profile and specific malaria interventions. Therefore, study aims at (1) identifying major sources of malaria funding in Zambia; (2) describing malaria funding per targeted interventions and (3) relating malaria funding with malaria disease burden between 2009 and 2018.


Study design

A retrospective cross-sectional study focused on institutional documents of the ministry of health main data repository. We performed a time series regression analysis with delta of one year factoring in data collected at time point 2009 to 2018 to capture any change that could have been repeated at each successive equally spaced time points to follow a sequence and an average of all time point taken to enable investigation of the pattern of change over time. Statistical package for social sciences (SPSS) alongside STATA version 16, were used to describe data and explain the relationship between the dependent variable malaria disease incidence by adopting and including seven (7) independent variables; insecticide treated nets (ITNs), case management (CM), indoor residual spray (IRS), mass drug administration (MDA), monitoring and evaluation (M&E), entomological studies (ES), information education and communication (IEC).Also stationarity test and variance inflation factor were employed on variables to investigate predictability and collinearity among variables respectively.). Thus, we adopted and included all the seven predictors related to the dependent variable into the model taking a form of standard multiple-linear equitation of the form Y = a + Bx1 + BX2 + BX3.

Statistical analysis used descriptive statistics that were quantitatively summarized from a collection of information from documents which included annual financial reports, and partner country operational plans which provide data on actual annual disbursement while other documents like medium term expenditure frameworks, strategic plans, evaluation of country programs, to mention but a few provide data on the budgets estimates and their assumption. Interestingly, all contributions received by the ministry of health from varies partners are expressed as annual disbursement. Also, administrative data such as malaria incidence and admissions were extracted from the District Health Management Information System accessed on (

Hypothesis testing was employed using the ANOVA single factor analysis of variance on malaria.

In addition, prior to data collection, ethical clearance was sought and granted in China from the institutional Review Board of China pharmaceutical University and approval from relevant authorities including Ministry of Health Public Health and Research Unit Zambia.


Additional file 1 Shows funding partners and reflects their mandate and area of support in the period under review. Contributors to malaria funding for malaria prevention, treatment and control in Zambia included Presidential Malaria Initiative (PMI-USAID), The Global Fund (GF), World Bank (WB), World Health Organization (WHO), United Nations International Children's Emergency Fund (UNICEF), Program for Appropriate Technology in Health (PATH), Malaria Control and Elimination Partnership in Africa (MACEPA) and Department for International Development (DfID) United Kingdom among others.

Disbursements directed to specific interventions in the study period showed a huge and continuous fluctuation in the annual funding disbursement from government and other stakeholders. According to the proportion of funds towards interventions, about 30% (95% CI: 24.43–33.62) of the funding came from PMI/USIAD, 26% (95% CI: 24.72–28.53) from the global funds. The government contributed 17% (95% CI: 16.03–18.46) with other partners sharing the remaining percentage.

Our findings indicated insecticide treated nets (ITNs) receiving a substantial amount of funding in the past 10 years representing about 34.7% of the total funding followed by IRS with 26.9%, clinical case management 19.0%, monitoring and evaluation 11.2% and information communication education 7.8%. While Support towards provision of mass drug administration and entomological surveillance were at 0.4% and 0.08% respectively Additional file 2. Additional file 3 Shows distribution of malaria intervention summarized as simple counts of proven support provided to ministry of health between the years 2009 and 2018. The results clearly indicates 26 institutions representing 24.1% of all institutions provided support towards Information Education and Communication (IEC), 23 institutions representing 21.3% support towards Indoor Residue Spray (IRS), 22 institutions representing (20.4%) support towards Case Management, 21 institutions representing 19.4% support towards provision of Insecticide Treated Nets (ITNs), 8 institutions representing 7.4% support towards M&E, 5 institutions representing 4.6% support towards Mass Drug Administration (MDA) and only 3 institutions representing 2.8% support towards entomological studies (ES).

Table 1 The District Health Information Management System (DHIS) indicated a systematic decline in number for patients admitted with malaria. Trend analysis of malaria admission showed over 60% (95% CI: 56.42–62.32) reduction from 176,664 to 68,898 admission cases denoting on average a reduction of 140,533 cases between the year 2009 and 2018. Data also suggest variation in annual malaria admission.

Table 1 Annual malaria admissions (2009–2018)

Table 2 Shows a notable difference in terms of amount of funds received per intervention, with ITNs, IRS, Case management, Monitoring & evaluation, and IEC receiving comparably larger allocation of funds. While mass drug administration and entomological surveillance showed missing data in the first 6 consecutive years of the review period. The average annual disbursement for all interventions from the year 2009 to 2018 was K32, 739,863 equivalent to USD $ 2,751,248. Furthermore, the highest annual average disbursement was towards ITNs at $5,923,341 while the least annual average was entomological surveillance at $807.

Table 2 Annual disbursement per intervention (ZMK)

Table 3 The single factor analysis of variance tests using the following null hypothesis: the number of admissions is equal and the alternative hypothesis: the number admissions is not equal, was performed to test equity of variances of reported malaria admissions by province. Results showed p-value < 0.00001 and significant at p < 0.05. Thus, we reject the null hypothesis indicating that there is sufficient evidence to suggest that reported malaria cases by provinces are statistically different.

Table 3 Single factor analysis of variance (malaria admission)

Table 4 Predictor variables explaining the relationship between funding and malaria incidence using the 95% confidence interval in the overall regression predictive model found a strong association between increasing funding towards selected key interventions and reducing occurrence of new cases of malaria.

Table 4 Regression analysis for malaria admission and funding in the year 2009 to 2018


Ministry of health has benefited from various malaria program interventions funds from more than 47 known partners. Local institutions and companies are also recorded to provide support mostly in interventions related to system straightening, program management and public health awareness. Thus, the study highlights the ministry of health having a long-standing, well established partnerships with a range of multilateral, governmental, nongovernmental, and private organizations providing support towards prevention, treatment and control of malaria in Zambia. It is worth noting that, through the district health management information system of the ministry of health which is mandated to collect routine data on service coverage and disease burden, analysis of malaria data indicated that there is a general decline in the number of reported malaria cases in the country [16]. Trend of malaria admissions falling over the years depicting over 60% (95% CI: 58.6–63.4) reduction between 2009 and 2018. However, the declining malaria disease burden is associated with geographical location [17]. Our research outcomes on single factor analysis of variance established a significant geographical variation in the number of reported malaria cases countywide with Eastern province recording highest number of patients admitted, followed by Luapula, North Western, Muchinga and Northern. While Southern and Lusaka reported lowest number of cases and a similar decline in annual malaria reported cases. On the other hand, Luapula province reported highest number of malaria deaths per annum. Copperbelt, Northern and Eastern provinces also reported high numbers of malaria related deaths. Although the number of reported malaria hospital admissions are seemingly high, the trend analysis showed declining malaria admission across all ten (10) provinces.

Furthermore, research results on insecticide treated nets showed a significant predictor value of 2.02612E−7 third after case management and indoor residual spraying in reducing the malaria burden provided one unit of addition investment towards funding. Interestingly, the use of ITNs in the fight against malaria in our study agrees with what was documented by Lengeler (2004) that in areas of stable malaria transmission, provisions of ITNs have potential to reduced parasite prevalence by 13%, uncomplicated malaria episodes by 50%, and severe malaria by 45% compared to equivalent populations with no nets [18, 19, 20]. Also, a study conducted in Zambia to determine ITNs integrity and insecticide content highlighted more availability of ITNs in households compared to previous years due to increases in funding for malaria control and continuous distribution of ITNs achieved through channels such as Antenatal Care, Expanded Program for Immunization and selected primary schools [21].

Analysis on indoor residual spraying was found to be significant in reducing the malaria disease burden with a 3.52625E-6 predictor value denoting greater change in health outcome per additional investment compared to other interventions in the study. Also, showed a consistent association between implementation of IRS and confirmed malaria case incidence, and a stronger association in reducing malaria disease burden. In Zambia IRS activities are conducted annually and these activities routinely include district-level planning and budgeting for targeted areas, assessment of spray structures, training of spray teams, supervision and monitoring of spray activities [22]

According to MOH (2011), Zambia IRS operations expanded from 5 districts in 2003, to 54 districts by 2014, with support from various partners including US President’s Malaria Initiative (PMI). The 2011–2015 National Malaria Strategic Plan recommended IRS in high-risk areas (a minimum of 85% of all targeted structures) with focalized IRS mounted in response to malaria surveillance data [23, 24].

In rural areas access to health care still remains a significant obstacle due to long distances to health facilities and challenges with transport among others. Consequently, many rural patients with malaria do not present to a health facility in time for treatment [25]. Owing to this, community health workers accustomed to high malaria incidence presumptively treat patients for malaria based on their clinical symptoms and this could potentially reduce the number of confirmed malaria cases recorded at health facilities as these interventions are not captured on time. In addition, clinicians had for a long time practiced a common non-evidence based “fever equals malaria” and treated patients as such without laboratory test /RDT results [26]. Owing to the interventions mentioned, our research findings showed case management to be significant in reducing malaria disease burden from the perspective of routine malaria cases recorded in the HMIS-based clinical records.

Mass drug administration is also a well know malaria prevention and control intervention worldwide. A community randomized step-wedged control trail was conducted in Southern Zambia to access effectiveness of population-wide malaria testing and treatment with rapid diagnostic tests and Artemether-Lumefantrine showed a strong inverse relationship. Moreover, A clear relationship between provision of MDA and reducing HMIS reported malaria burden was noticed in the lower transmission strata, malaria parasite prevalence declined from 7.7% at baseline to 0.5% after the first two MDA rounds, an 87% larger decline than seen in the control group [27]. Similarly, our results showed MDA being significant in reducing disease burden though with the least predictor value of 1.37886E-8 when compared with other interventions analyzed and to the previous studies indicating mass drug administration having a strong predictor power to prevent the spread of the disease. The lower predictor power can be attributed to limited data in the years reported in the study.

However, data for information education communication and M&E were not significant in reducing disease burden and showed a week positive relationship between the intervention and annual malaria reported cases. Thus, this would imply that the more the community is informed or educated about malaria, the more likely they will visit the hospital to seek medical services and as such the number of reported cases recorded is expected to increase. In addition, M&E would suggest the number of reported malaria cases recorded increase as more activities to monitor collection of such data are employed.

Malaria transmission is driven by a complex interaction of the vector, parasite, human host, and the environment, and governed by different ecological and social determinants. Human population increase, developmental activities and associated ecological transformations have a significant impact on malaria epidemiology and have invariably exacerbated the situation. Malaria transmission depends markedly on local environmental conditions and other compounding factors, that is, presence of drug-resistant parasites and insecticide resistant vectors, environmental changes, and economy, poverty levels, climatic changes, natural disasters and political instability, adaptability of malaria vectors to changing environments and limited investment in research, and optimization of malaria vector control programs [28]. Thus, entomological surveillance is also important in the estimation of the expected impact of the various control measures on reducing disease burden though our research outcomes were not significant owing to missing data and also having the least percentage of 2.8% representing the number of institutions supporting the intervention. Data is suggestive of need to sustained investment in entomological surveillance to have adequate samples to measure mean mosquito densities.

In the period reported approximately $ 2.8 million from the selected key interventions was invested into different malaria prevention and curative and diagnostic programs each year. Though the finances ploughed into the key interventions are believed to be potentially higher than the estimation captured in this study, as donations and actual budget allocations from the government of Zambia through the ministry of health would increase the financial investment towards reducing malaria burden if incorporated.

Our findings are suggestive of the pronounced decline in malaria disease burden over the study periods as a consequence of increase in annual funding towards preventive, control and curative interventions. Also, much of this success in the decline could be credited to a combination of sustained economic growth, behavioral change, change in the use of agricultural pesticides or insecticide-like compounds not directly applied for targeting malaria vectors, changes in housing from traditional to modern houses, better surveillance, and improved access to health services in rural areas as a result of newly built health posts reducing the distance from homes to health facilities and an increased number of community health workers [29, 30, 31]. The overall regression predictive model in this study found a strong association between increasing funding towards selected key interventions and reducing occurrence of new cases of of malaria owing to research outcomes indicating about 77% of variations in HMIS-recorded clinical malaria burden could statistically be concurrent to increase in funding towards programs/interventions between the years 2009 and 2018. It is worth noting that, there may be an intriguing link to recent changes in social and ecological sittings that requires further investigation and other potential explanations for the observed decline in disease burden. Hence, need to include an assessment of the potential role of changes in global warming, proper water drainage during rain seasons, and agricultural related use of chemicals, land use, deforestation, and entomological surveillance to reducing the disease burden. Relatedly, the Zambia national malaria program performance review report of 2010, confirms that combined funding for malaria prevention methods (IRS, ITNS, and other vector bone methods) are more compared to treatment and diagnostics methods due to their huge impact on the disease burden [32].

Methodological problems were encountered in this research with primary limitations of this research method being the high cost of research owing to the number of study areas needed in time-series design, the challenges in developing generalizable theoretical principles about community change processes through retrospective data collected, the obscuring of relationships that are unique to a subset of communities, and the problem of diffusion of intervention activities from intervention to control the area of study.

Moreover, it is a cross-sectional study in which the analysis was descriptive and recall bias due to the retrospective nature of data collection related to variables as well as desirability bias may further have an affect the results outcomes of the analysis. In addition, bias-variance may affect the results. Ideally, averaging multiple observations using information from larger regions would reduce the bias—variance from high variance resulting from algorithm modeling the random noise in the data in a model that is over fitted. Also, we conducted our research from the perspective of malaria disease burden routinely recorded in the HMIS-based clinical records while there is also the wider population-level burden seen through population-based household surveys e.g. malaria parasite infection prevalence in DHS, MICS or Malaria indicator survey which typically does not fully access records. In addition, investment will have a lag before the service reaches its beneficiaries. However, an assumption of a one-year time lag was suggested across all interventions while specific interventions such as ITNs distributions leads to protection over 2–3 years, IRS impact limited between 6 and 12 months following spraying and case management benefits in terms of avoiding hospitalization are relatively immediate. Hence, using fixed effects potentially produce similar results and differing on predictor power.


Malaria funding support is largely targeted towards mass drug administration, indoor residue spray, insecticide treated bed nets, clinical case management (provision of anti-malarial drugs, laboratory diagnostic equipment), entomological intervention, monitoring and evaluation, and information Education/ communication. Further studies are needed to evaluate the relationship between all know malaria interventions against disease burden. Also, finding more efficient and cost-effective ways of developing and evaluating interventions which could be of great benefit to individual health and well-being of a nation or region as addition lives will be saved if we learn how to develop area study interventions more efficiently.

Availability of data and materials

The dataset used/analysed are available from the corresponding author on request.


  1. Romero M, Leiba E, Carrión-Nessi FS, et al. Malaria in pregnancy complications in Southern Venezuela. Malar J. 2021;20:186.

    Article  PubMed  PubMed Central  Google Scholar 

  2. WHO (World Health Organization). World malaria report 2015. Geneva: WHO; 2015.

    Book  Google Scholar 


  4. Nawa M, Hangoma P, Morse AP, et al. Investigating the upsurge of malaria prevalence in Zambia between 2010 and 2015: a decomposition of determinants. Malar J. 2019;18:61.

    Article  PubMed  PubMed Central  Google Scholar 


  6. Korenromp E, Hamilton M, Sanders R, et al. Impact of malaria interventions on child mortality in endemic African settings: comparison and alignment between LiST and Spectrum-Malaria model. BMC Public Health. 2017;17:781.

    Article  PubMed  PubMed Central  Google Scholar 


  8. Kaonga O, Banda C, Masiye F. Hardship financing of out-of-pocket payments in the context of free healthcare in Zambia. PLoS ONE. 2019;14(4):e0214750. (Published 2019 Apr 10).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chipukuma HM, Zulu JM, Jacobs C, et al. Towards a framework for analyzing determinants of performance of community health workers in malaria prevention and control: a systematic review. Hum Resour Health. 2018;16:22.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kok MC, Dieleman M, Taegtmeyer M, Broerse JE, Kane SS, Ormel H, Tijm MM, de Koning KA. Which intervention design factors influence performance of community health workers in low- and middle-income countries? A systematic review. Health Policy Plan. 2015;30(9):1207–27.

    Article  PubMed  Google Scholar 


  12. Dzeing-Ella A, Nze Obiang PC, Tchoua R, et al. Severe falciparum malaria in Gabonese children: clinical and laboratory features. Malar J. 2005;4:1.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chizema-Kawesha E, Miller JM, Steketee RW, Mukonka VM, Mukuka C, Mohamed AD, Miti SK, Campbell CC. Scaling up malaria control in Zambia: progress and impact 2005–2008. Am J Trop Med Hyg. 2010;83(3):480–8.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Okumu FO, Moore SJ. Combining indoor residual spraying and insecticide-treated nets for malaria control in Africa: a review of possible outcomes and an outline of suggestions for the future. Malar J. 2011;10:208.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Manyando C, Njunju EM, Chileshe J, et al. Rapid diagnostic tests for malaria and health workers’ adherence to test results at health facilities in Zambia. Malar J. 2014;13:166.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mutemwa RI. HMIS and decision-making in Zambia: re-thinking information solutions for district health management in decentralized health systems. Health Policy Plan. 2005;21(1):40–52.

    Article  PubMed  Google Scholar 

  17. Lubinda J, Bi Y, Hamainza B, Haque U, Moore AJ. Modelling of malaria risk, rates, and trends: a spatiotemporal approach for identifying and targeting sub-national areas of high and low burden. PLoS Comput Biol. 2021;17(3): e1008669.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Christian Lengeler (2004). Insecticide‐treated bed nets and curtains for preventing malaria cochrane systematic review—intervention version published: 19 April 2004 see what's Retrieved March 9, 2019.



  21. Craig AS, Muleba M, Smith SC, et al. Long-lasting insecticidal nets in Zambia: a cross-sectional analysis of net integrity and insecticide content. Malar J. 2015;14:239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Keating J, Yukich JO, Miller JM, et al. Retrospective evaluation of the effectiveness of indoor residual spray with pirimiphos-methyl (Actellic) on malaria transmission in Zambia. Malar J. 2021;20:173.

    Article  CAS  PubMed  PubMed Central  Google Scholar 


  24. Pinchoff J, Larsen DA, Renn S, Pollard D, Fornadel C, Maire M, Sikaala C, Sinyangwe C, Winters B, Bridges DJ, Winters AM. Targeting indoor residual spraying for malaria using epidemiological data: a case study of the Zambia experience. Malar J. 2016;15:11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Littrell M, Miller JM, Ndhlovu M, Hamainza B, Hawela M, Kamuliwo M, Hamer DH, Steketee RW. Documenting malaria case management coverage in Zambia: a systems effectiveness approach. Malar J. 2013;12:371.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Masaninga F, Sekeseke-Chinyama M, Malambo T, et al. Finding parasites and finding challenges: improved diagnostic access and trends in reported malaria and anti-malarial drug use in Livingstone district, Zambia. Malar J. 2012;11:341.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Silumbe K, Yukich JO, Hamainza B, Bennett A, Earle D, Kamuliwo M, Steketee RW, Eisele TP, Miller JM. Costs and cost-effectiveness of a large-scale mass testing and treatment intervention for malaria in Southern Province, Zambia. Malar J. 2015;14:211.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chanda E, Baboo KS, Shinondo CJ. Transmission attributes of periurban malaria in Lusaka, Zambia, precedent to the integrated vector management strategy: an entomological input. J Trop Med. 2012;2012:1–8. (Article ID 873852).

    Article  Google Scholar 

  29. Chanda E, Hemingway J, Kleinschmidt I, Rehman AM, Ramdeen V, Phiri FN, et al. Insecticide resistance and the future of malaria control in Zambia. PLoS ONE. 2011;6(9): e24336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ippolito MM, Searle KM, Hamapumbu H, Shields TM, Stevenson JC, Thuma PE, Moss WJ. House structure is associated with plasmodium falciparum infection in a low-transmission setting in Southern Zambia. Am J Trop Med Hyg. 2017;97(5):1561–7. (Epub 2017 Aug 18. PMID: 28820722; PMCID: PMC5817773).

    Article  PubMed  PubMed Central  Google Scholar 

  31. Chipukuma HM, Halwiindi H, Zulu JM, et al. Evaluating fidelity of community health worker roles in malaria prevention and control programs in Livingstone District, Zambia-a bottleneck analysis. BMC Health Serv Res. 2020;20:612.

    Article  PubMed  PubMed Central  Google Scholar 


Download references


We would like to express our special thanks to the Zambian Ministry of Health, Monitoring and Evaluation unit for giving us access to the district health information system (DHIS2) to extract primary data for this study.


There is no funding for this study.

Author information

Authors and Affiliations



MM, WX, and AC contributed to the conceptualization of the study. The design by MM, KSA, MA, JLM and DWW. Data collection by MM, JLM, MM, XZY, DWW, KSA and JLM analysed and interpreted the data.MM and XZY wrote the first draft of the manuscript. MA, and WX revised the article for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Wei Xu.

Ethics declarations

Ethics approval and consent to participate

This study received ethical approval in China from the institutional review Board of China Pharmaceutical University (Nanjing, China). While in Zambia from the National Health Research Authority (NHRA), Ministry of Health Public Health and Research Unit and relevant authorities in the Ministry of Health.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

. Sources of Malaria Disbursement in Zambia.

Additional file 2

. Proportion of disbursement towards interventions.

Additional file 3

. Support towards malaria intervention.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mtalimanja, M., Abasse, K.S., Abbas, M. et al. Tracking malaria health disbursements by source in Zambia, 2009–2018: an economic modelling study. Cost Eff Resour Alloc 20, 34 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Malaria interventions
  • Disease Burden
  • Malaria funding
  • Zambia